TD Ameritrade Investment Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-383
Closed -$71K 87
2023
Q2
$71K Sell
383
-27
-7% -$4.99K ﹤0.01% 238
2023
Q1
$78K Sell
410
-92
-18% -$16.6K ﹤0.01% 238
2022
Q4
$84K Sell
502
-144
-22% -$25K ﹤0.01% 242
2022
Q3
$114K Sell
646
-103
-14% -$20.4K ﹤0.01% 239
2022
Q2
$153K Sell
749
-176
-19% -$37.3K ﹤0.01% 238
2022
Q1
$220K Buy
925
+89
+11% +$20.9K ﹤0.01% 235
2021
Q4
$191K Buy
836
+189
+29% +$41.6K ﹤0.01% 241
2021
Q3
$108K Sell
647
-246
-28% -$49.8K ﹤0.01% 250
2021
Q2
$190K Buy
893
+231
+35% +$48.8K ﹤0.01% 239
2021
Q1
$121K Hold
662
﹤0.01% 255
2020
Q4
$121K Buy
662
+15
+2% +$2.55K ﹤0.01% 255
2020
Q3
$108K Buy
647
+66
+11% +$11.1K ﹤0.01% 250
2020
Q2
$94K Buy
581
+53
+10% +$9.5K ﹤0.01% 250
2020
Q1
$91K Buy
528
+6
+1% +$1.19K ﹤0.01% 244
2019
Q4
$105K Buy
522
+70
+15% +$14.4K ﹤0.01% 238
2019
Q3
$96K Buy
452
+318
+237% +$66.4K ﹤0.01% 216
2019
Q2
$26K Buy
134
+128
+2,133% +$23.6K ﹤0.01% 311
2019
Q1
$1K Hold
6
﹤0.01% 542
2018
Q4
$1K Hold
6
﹤0.01% 555
2018
Q3
$1K Hold
6
﹤0.01% 526
2018
Q2
$1K Buy
+6
New +$980 ﹤0.01% 409

Other funds holding CME

TD Ameritrade Investment Management's CME Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of CME Group (CME) in Q3 2023, closing a stake of 383 shares — an estimated $71K sold.

TD Ameritrade Investment Management first reported a position in CME in Q2 2018 and held it in 21 quarters. The position peaked at $220K in Q1 2022. 1,229 funds tracked by Wall St. Rank hold CME as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining CME Group position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 383 CME Group shares in Q3 2023, an estimated $71K.
  • TD Ameritrade Investment Management first reported a position in CME Group in Q2 2018 and held it in 21 quarters.
  • TD Ameritrade Investment Management's CME Group position peaked at $220K in Q1 2022.
  • 1,229 funds tracked by Wall St. Rank held CME Group as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.